DENTSPLY SIRONA (NASDAQ:XRAY) Trading Down 8.4% - Here's What Happened

Key Points

• DENTSPLY SIRONA shares fell 8.4% to about $12.06 in Friday’s mid-day trading, with volume significantly below the stock’s average session volume.
• Analyst sentiment remains cautious: the stock has a consensus “Hold” rating and a $13.54 target price, with recent target changes ranging from $9.00 to $14.00.
• The company beat quarterly expectations with $0.52 in EPS versus $0.35 expected and $898 million in revenue, but revenue declined 4.1% year over year and the company reported a negative net margin.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Get Free Report)'s share price dropped 8.4% during mid-day trading on Friday . The stock traded as low as $12.08 and last traded at $12.0640. 1,294,629 shares traded hands during mid-day trading, a decline of 74% from the average session volume of 5,021,003 shares. The stock had previously closed at $13.17.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on XRAY. Barclays reduced their target price on shares of DENTSPLY SIRONA from $12.00 to $9.00 and set an "underweight" rating on the stock in a research report on Thursday, June 4th. Piper Sandler boosted their price target on DENTSPLY SIRONA from $13.00 to $14.00 and gave the company a "neutral" rating in a report on Wednesday, July 29th. Mizuho dropped their price objective on DENTSPLY SIRONA from $16.00 to $14.00 and set a "neutral" rating on the stock in a research note on Wednesday, May 6th. Citigroup started coverage on DENTSPLY SIRONA in a report on Wednesday, April 15th. They set a "sell" rating and a $10.00 price objective on the stock. Finally, BMO Capital Markets reaffirmed a "market perform" rating and set a $13.00 target price on shares of DENTSPLY SIRONA in a research report on Friday. Three investment analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus target price of $13.54.

DENTSPLY SIRONA Stock Performance

The firm's fifty day moving average price is $11.74 and its 200 day moving average price is $11.89. The firm has a market cap of $2.44 billion, a P/E ratio of -3.87, a price-to-earnings-growth ratio of 1.64 and a beta of 0.85. The company has a debt-to-equity ratio of 1.52, a quick ratio of 0.98 and a current ratio of 1.53.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its quarterly earnings data on Thursday, August 6th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.35 by $0.17. The company had revenue of $898.00 million for the quarter, compared to analyst estimates of $889.93 million. DENTSPLY SIRONA had a negative net margin of 17.06% and a positive return on equity of 18.83%. DENTSPLY SIRONA's revenue was down 4.1% compared to the same quarter last year. During the same period last year, the company posted $0.52 earnings per share. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. Sell-side analysts expect that DENTSPLY SIRONA Inc. will post 1.42 EPS for the current fiscal year.

Insider Activity

In related news, Director Michael J. Barber purchased 15,175 shares of the business's stock in a transaction dated Thursday, June 11th. The shares were acquired at an average cost of $9.88 per share, for a total transaction of $149,929.00. Following the acquisition, the director owned 55,943 shares of the company's stock, valued at $552,716.84. The trade was a 37.22% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Brian T. Gladden acquired 9,985 shares of the firm's stock in a transaction that occurred on Monday, June 15th. The shares were bought at an average price of $10.02 per share, with a total value of $100,049.70. Following the completion of the purchase, the director directly owned 61,849 shares in the company, valued at $619,726.98. The trade was a 19.25% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. In the last three months, insiders have purchased 35,160 shares of company stock worth $351,179. 0.46% of the stock is currently owned by company insiders.

Institutional Trading of DENTSPLY SIRONA

Several hedge funds have recently modified their holdings of XRAY. First Eagle Investment Management LLC increased its holdings in shares of DENTSPLY SIRONA by 3.2% during the fourth quarter. First Eagle Investment Management LLC now owns 14,640,555 shares of the medical instruments supplier's stock valued at $167,342,000 after acquiring an additional 458,744 shares in the last quarter. Great Hill Capital LLC acquired a new stake in DENTSPLY SIRONA in the 4th quarter worth approximately $8,267,000. UBS Group AG grew its position in DENTSPLY SIRONA by 63.7% during the 4th quarter. UBS Group AG now owns 1,701,980 shares of the medical instruments supplier's stock worth $19,454,000 after purchasing an additional 662,000 shares during the last quarter. Fiduciary Alliance LLC purchased a new stake in DENTSPLY SIRONA during the 1st quarter worth approximately $4,607,000. Finally, SG Americas Securities LLC acquired a new position in DENTSPLY SIRONA during the 4th quarter valued at approximately $1,064,000. 95.70% of the stock is owned by hedge funds and other institutional investors.

About DENTSPLY SIRONA

Dentsply Sirona Inc NASDAQ: XRAY is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company's product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source